SPI Energy +34.46% Submits Notification of Late Filing
Jeff Kagan: Apple Needs New Visionary
Why is Everyone Selling China Customer Relations Centers (CCRC)?
What Will the Boss Say About Sophiris (SPHS) This Afternoon?
FDA-Approved Study on Hemopurifier could Protect Against Zika
Cameron Reynolds of VolitionRX Ltd. ($VNRX) sits down with Equities.com to discuss the company's blood-based diagnostic tests for cancer.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2015 Equities
*All dates and time are being displayed in Eastern Standard Time (EST).